Detailansicht

Wissensnetz

Person

Lukas Pekar (1990-)

Chemiker

Name	Lukas Pekar
Zeit	1990- (Lebensdaten)
Ort	Flörsheim am Main (Geburtsort) Darmstadt (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. rer. nat.
Beruf	Chemiker (charakteristischer Beruf)
Beziehung	Institut für Biochemie (Darmstadt)
Datensatztyp	Person
GND-Nummer	1257644238
Datensatz-ID	1257644238
Beteiligt an alle anzeigen Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats Antibody display technologies: selecting the cream of the crop Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of ‘Almost Natural’ Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection Novel technologies for antibody hit discovery and engineering of antibody-like proteins with therapeutic relevance

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Lukas Pekar (1990-)

Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features

Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features

Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity

NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats

Antibody display technologies: selecting the cream of the crop

Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of ‘Almost Natural’ Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection

Novel technologies for antibody hit discovery and engineering of antibody-like proteins with therapeutic relevance